Gardasil Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Gardasil Injection is a human papillomavirus (HPV) vaccine. Its labelling describes it as being given to help prevent HPV-associated cancers — including cervical, vaginal, vulvar and anal cancers — and genital warts caused by HPV types 6 and 11, and it is described for males and females between 9 and 26 years of age. It is described as not being a treatment for an existing HPV infection or related conditions.
Product Information
The following description reflects information associated with the human papillomavirus (HPV) vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of HPV-associated cancers, including cervical, vaginal, vulvar and anal cancers
- Described for the prevention of genital warts (skin bumps on or around the genital or anal area) caused by HPV types 6 and 11
- Described for males and females between 9 and 26 years of age; described as giving longer-term protection when given early
Described How It Works
Its labelling describes the vaccine as prompting the immune system to produce antibodies against certain HPV strains, so the body is better able to respond to those strains on future exposure. It does not contain live virus capable of causing HPV disease.
Described Dosage & Administration
- Administered only by a healthcare professional as an intramuscular injection — not self-administered
- Described as given as a course of 2 to 3 doses spaced several months apart, on the schedule set by the healthcare provider
- The full course of vaccination should be completed for maximum benefit
Described Side Effects
Commonly described side effects include:
- Injection-site reactions (pain, swelling, redness)
- Headache
- Fever
- Dizziness
- Nausea
These are described as usually mild and temporary. A doctor should be consulted if they persist, and any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- It is described as not being used to treat an existing HPV infection or other established conditions
- Vaccination is described as not removing the need for safe sexual-health practices and regular medical check-ups, including recommended cervical screening
- Any previous allergic reaction to a vaccine or vaccine component should be disclosed before administration
- Pregnancy or breastfeeding should be discussed with the healthcare provider before the vaccine is given
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it is an HPV vaccine given to help prevent HPV-associated cancers (cervical, vaginal, vulvar and anal) and genital warts caused by HPV types 6 and 11, in males and females between 9 and 26 years of age. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes a course of 2 to 3 doses given several months apart by a healthcare professional as an intramuscular injection. The full course should be completed for maximum benefit.
No. Its labelling describes it as preventive only — it is not used to treat an existing HPV infection or related conditions, and it does not replace safe sexual-health practices or recommended screening.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.